Case Study: Fidia Farmaceutici strengthens OT security and regulatory compliance with Claroty xDome

Fidia Farmaceutici secures 1,700-employee operations with Claroty and 3-year NIS2 readiness

Fidia Farmaceutici, an Italian multinational pharmaceutical company, faced significant cybersecurity challenges due to the convergence of its IT and operational technology (OT) environments. Their legacy systems, heterogeneous infrastructure, and strict regulatory requirements made traditional security updates and large-scale overhauls impractical, as any downtime would severely impact production. The company needed a way to gain visibility and control without disrupting its critical pharmaceutical manufacturing processes. To address this, they partnered with the vendor Claroty.

Claroty implemented its xDome platform and Secure Access solution, establishing a 'Cybersecurity by Design' approach. The solution provided passive monitoring, structural domain segregation, and Zero Trust remote access management. As a result, Fidia achieved an automated, continuously updated asset inventory, optimized resources, and enhanced traceability for regulatory compliance with standards like NIS2 and GAMP 5. Claroty enabled Fidia to proactively manage risks and accelerate anomaly diagnosis without halting production, securing their vital infrastructure.

Fidia Farmaceutici